Healthcare: Is It (Finally) OK To Buy Valeant and Gilead Sciences Again?

<p>We dig into Valeant and Gilead Sciences' first quarter financials to see if shares are a bargain, or a bust.</p> <p>Thanks to Slack for supporting The Motley Fool.  Learn more at <a href="http://www.slack.com">slack.com</a>.</p>